Alnylam Pharmaceuticals (ALNY) Cash & Equivalents (2009 - 2026)
Alnylam Pharmaceuticals' Cash & Equivalents came in at $1.71 billion for Q2 2026, up 53.4% from $1.11 billion a year earlier but down 0.1% from the prior quarter.
Powered by 
Analysis
Alnylam Pharmaceuticals (ALNY) Cash & Equivalents (2009 - 2026) Analysis & Trends
At the end of FY2025, Alnylam Pharmaceuticals' Cash & Equivalents was $1.66 billion, up 71.1% from FY2024.
- Cash & Equivalents carries a five-year compound annual growth rate of 27.1% (FY2020 to FY2025).
- Going back by year, Cash & Equivalents was $968.65 million in FY2024 (+19.2%), $812.69 million in FY2023 (-6.4%), $868.56 million in FY2022 (+5.6%) and $822.15 million in FY2021 (+64.7%).
- The five-year range for quarterly Cash & Equivalents is $534.08 million (Q1 2022) to $1.71 billion (Q1 2026).
- Year-over-year, Cash & Equivalents has increased for ten consecutive quarters, with growth averaging 39.7% over the last eight quarters.
- The fastest year-over-year change in Cash & Equivalents over five years came in Q3 2021 (growth of 120.3%), and the weakest in Q2 2022 (a decline of 22.8%).
- Business Quant data shows ALNY's Cash & Equivalents at $1.71 billion (Q1 2026), $1.66 billion (Q4 2025) and $1.49 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,144.36 Bn | 1,112.95 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.36 Bn | 555.22 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 502.79 Bn | 475.90 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.08 Bn | 310.46 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 300.87 Bn | 264.86 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 264.31 Bn | 237.99 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 239.07 Bn | 194.47 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.50 Bn | 168.70 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.00 Bn | 117.64 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Alnylam Pharmaceuticals | 29.96 Bn | 18.01 Bn | 992.69 Mn | 1.71 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.71 Bn |
| Mar 31, 2026 | 1.71 Bn |
| Dec 31, 2025 | 1.66 Bn |
| Sep 30, 2025 | 1.49 Bn |
| Jun 30, 2025 | 1.11 Bn |
| Mar 31, 2025 | 1.02 Bn |
| Dec 31, 2024 | 968.65 Mn |
| Sep 30, 2024 | 1.10 Bn |
| Jun 30, 2024 | 968.49 Mn |
| Mar 31, 2024 | 681.88 Mn |
| Dec 31, 2023 | 812.69 Mn |
| Sep 30, 2023 | 1.03 Bn |
| Jun 30, 2023 | 657.80 Mn |
| Mar 31, 2023 | 672.25 Mn |
| Dec 31, 2022 | 868.56 Mn |
| Sep 30, 2022 | 1.07 Bn |
| Jun 30, 2022 | 575.56 Mn |
| Mar 31, 2022 | 534.08 Mn |
| Dec 31, 2021 | 822.15 Mn |
| Sep 30, 2021 | 1.09 Bn |
API Access
Alnylam Pharmaceuticals Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ALNY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "ALNY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ALNY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();